Avantra Family Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Buy
1,602
+99
+7% +$36.7K 0.4% 83
2026
Q1
$440K Buy
+1,503
New +$494K 0.33% 91
2025
Q3
Sell
-1,365
Closed -$531K 167
2025
Q2
$531K Sell
1,365
-185
-12% -$74.4K 0.44% 65
2025
Q1
$674K Buy
1,550
+36
+2% +$14.5K 0.65% 54
2024
Q4
$559K Buy
+1,514
New +$634K 0.52% 60

Other funds holding ELV

Avantra Family Wealth's ELV Position: Q2 2026 in Review

Avantra Family Wealth increased its Elevance Health (ELV) stake by 6.6% in Q2 2026, buying an estimated $36.7K and bringing the position to 1,602 shares worth $620K. The position accounts for 0.4% of the portfolio, ranked #83.

Avantra Family Wealth first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $674K in Q1 2025. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Avantra Family Wealth held 1,602 shares of Elevance Health worth $620K as of Q2 2026.
  • Avantra Family Wealth bought 99 Elevance Health shares in Q2 2026, an estimated $36.7K.
  • Elevance Health made up 0.4% of Avantra Family Wealth's portfolio in Q2 2026, its #83 holding.
  • Avantra Family Wealth first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • Avantra Family Wealth's Elevance Health position peaked at $674K in Q1 2025.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Avantra Family Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.